Trane Technologies: Regnery proposes $23.1M sale

The notice reports 220,023,177 shares of common stock outstanding.

Rhea-AI Filing Summary

Trane Technologies plc (TT) lists a notice for the sale of 48,091 common shares for David S. Regnery’s account through UBS Financial Services, with an approximate sale date of October 6, 2026, and an aggregate market value of $23,083,680. The notice says the shares were acquired from the issuer through exercise of stock options for cash on October 6, 2026. It also reports 43,778 common shares sold on August 5, 2026, with a reported value of $20,794,550.

Key Figures

Shares listed for sale: 48,091 common shares Aggregate market value of shares listed for sale: $23,083,680 Common shares outstanding: 220,023,177 shares +2 more

5 metrics

Shares listed for sale 48,091 common shares Approximate sale date: October 6, 2026

Aggregate market value of shares listed for sale $23,083,680 Notice for sale

Common shares outstanding 220,023,177 shares Issuer information

Shares sold during the past three months 43,778 common shares Sale date: August 5, 2026

Value reported for shares sold during the past three months $20,794,550 Sale date: August 5, 2026

Key Terms

Exercise of Stock Options, attorney-in-fact, Rule 144

3 terms

Exercise of Stock Options financial

"Exercise of Stock Options"

attorney-in-fact regulatory

"as attorney-in-fact for David Regnery"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TT shares is David S. Regnery’s notice for?

The notice lists 48,091 common shares for sale through UBS Financial Services, with an approximate sale date of October 6, 2026, and an aggregate market value of $23,083,680.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 04:03 PM Accepted by SEC EDGAR 10/06/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001715932
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Trane Technologies plc
SEC File Number	001-34400
Address of Issuer	170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, CO. DUBLIN IRELAND 00000
Phone	732-652-7000
Name of Person for Whose Account the Securities are To Be Sold	Regnery David S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 11 Madison Ave 4th Floor New York NY 10010	48091	23083680.00	220023177	10/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/06/2026	Exercise of Stock Options	Issuer			48091	10/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Regnery c/o 170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, Dublin L2 00000	Common	08/05/2026	43778	20794550.00

144: Remarks and Signature

Remarks
Date of Notice	10/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for David Regnery
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)